Form 8-K - Current report:
SEC Accession No. 0001104659-21-119377
Filing Date
2021-09-24
Accepted
2021-09-24 17:19:27
Documents
16
Period of Report
2021-09-20
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2128347d1_8k.htm   iXBRL 8-K 33390
2 EXHIBIT 16.1 tm2128347d1_ex16-1.htm EX-16.1 3652
7 GRAPHIC image_002.gif GRAPHIC 1583
8 GRAPHIC image_003.gif GRAPHIC 1250
  Complete submission text file 0001104659-21-119377.txt   264955

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA fbio-20210920.xsd EX-101.SCH 3769
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fbio-20210920_def.xml EX-101.DEF 27402
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE fbio-20210920_lab.xml EX-101.LAB 37129
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fbio-20210920_pre.xml EX-101.PRE 26027
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2128347d1_8k_htm.xml XML 5449
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35366 | Film No.: 211278275
SIC: 2834 Pharmaceutical Preparations